NEO

NEOGENOMICS, INC.

NEO · CIK 1077183 · Annual (10-K) · Last 8 years

Financial Trends

Revenue
20182025
Net Income−$108M
20182025
Operating CF$5M
20182025
Free Cash Flow−$22M
20182025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Revenue————————
Cost of Revenue$0.4B$0.4B$0.3B$0.3B$0.3B$0.3B$0.2B$0.1B
Gross Profit$0.3B$0.3B$0.2B$0.2B$0.2B$0.2B$0.0B$0.0B
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.1B$-0.1B$-0.1B$-0.2B$-0.1B$-0.0B$0.0B$0.0B
Net Income$-0.1B$-0.1B$-0.1B$-0.1B$-0.0B$0.0B$0.0B$0.0B
EPS (Basic)————————
EPS (Diluted)————————

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Total Assets$1.4B$1.6B$1.7B$1.7B$1.9B$1.0B$0.7B$0.5B
Current Assets$0.4B$0.6B$0.6B$0.6B$0.7B$0.4B$0.3B$0.1B
Cash & Equivalents$0.2B$0.4B$0.3B$0.3B$0.3B$0.2B$0.2B$0.0B
Total Liabilities$0.5B$0.7B$0.7B$0.7B$0.8B$0.3B$0.2B$0.2B
Current Liabilities$0.1B$0.3B$0.1B$0.1B$0.1B$0.1B$0.1B$0.1B
Stockholders' Equity$0.8B$0.9B$0.9B$1.0B$1.1B$0.7B$0.5B$0.3B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕
Operating Cash Flow$0.0B$0.0B$-0.0B$-0.1B$-0.0B$0.0B$0.0B—
Investing Cash Flow$-0.0B$0.0B$0.1B$0.0B$-0.6B$-0.2B$-0.0B—
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B
Financing Cash Flow$-0.2B$0.0B$0.0B$0.0B$0.7B$0.2B$0.2B—
← Companies